Arthritis/rheumatic disorders:
Indications for: EUFLEXXA
Osteoarthritis of the knee in patients who have failed nonpharmacologic therapy and analgesics (eg, acetaminophen).
Adult Dosage:
Prior to treatment: remove joint effusion (use separate syringe), if present. Inject 2mL (full syringe contents) intra-articularly in each affected knee weekly for 3 weeks. Use separate syringes for each knee.
Children Dosage:
Not recommended.
EUFLEXXA Contraindications:
Knee joint infection or skin disease at inj site.
EUFLEXXA Warnings/Precautions:
Repeated treatment cycles: not established. Avoid intravascular injection. Avoid strenuous activity within 48hrs after injection. Pregnancy. Nursing mothers.
EUFLEXXA Classification:
Hyaluronan.
EUFLEXXA Interactions:
Avoid disinfectants with quaternary ammonium salts. Concomitant other intra-articular injectables: not recommended.
Adverse Reactions:
Arthralgia, increase blood pressure, inj site pain, local reactions, transient knee inflammation.
How Supplied:
Single-use prefilled syringes (2mL)—1
